Aswin K Mohan։ Intravenous Iron in Heart Failure and Infection Risk
Aswin K Mohan, Medicine Specialist at AIIMS Bibinagar, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Open Heart, adding:
”Happy to share our latest publication in BMJ Open Heart!
‘Infection risk and clinical outcomes with intravenous iron in adults with heart failure and iron deficiency: a systematic review and meta-analysis of randomised controlled trials.’
Our study examined 18 independent trial cohorts to evaluate the benefits and infection-related risks of intravenous iron therapy in patients with heart failure and iron deficiency.
Key findings:
Intravenous iron probably reduces heart failure-related hospitalisations.
No clear increase in infection risk was observed, although the evidence remains uncertain.
Little or no effect on overall mortality was demonstrated.
These findings add to the growing evidence supporting intravenous iron therapy while highlighting the need for better infection-related safety reporting.”
Title: Infection risk and clinical outcomes with intravenous iron in adults with heart failure and iron deficiency: a systematic review and meta-analysis of randomised controlled trials
Authors: Saikat Mandal, Joyisa Deb, Vaidehi Prasanth, Aswin K Mohan, Justin Jose, So Ahng Yoon, Manideepa Maji, Asmita Goswami, Anindya Mukherjee, Arkadeep Dhali
More posts featuring Aswin K Mohan on Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian